Follow up of High Myopic Eyes

Pathologic Myopia Clinical Trial

— FWUPMIOPIA_ E  

Official title:

Long Term Follow-up of Eyes With High Myopia

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06322433
• Other study ID #: 37C301
• Status: Recruiting
• Start date: November 1, 2023
• Est. completion date: November 1, 2025

Study information

• Verified date: March 2024
• Source: Istituto Auxologico Italiano
• Contact: Paolo Milani, MD
• Phone: +390261911
• Email: dottpaolomilani[@]hotmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In this non-interventional retrospective and prospective observational study, the long-term evolution of clinical and iconographic characteristics of patients with pathological myopia will be considered Changes of some specific clinical, tomographic and angiographic variables evaluated on the baseline and after a minimum of 5 years follow-up will be studied.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 138
• Est. completion date: November 1, 2025
• Est. primary completion date: November 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• high myopia

Exclusion Criteria:

• acute ischemic optic neuropathy
• macular and peripapillary atrophy
• other forms of maculopathy

Related Conditions & MeSH terms

• Myopia
• Pathologic Myopia

Intervention

Diagnostic Test:
• no drugs used for this study
tomographic, angiographic and clinical follow up

Locations

Country	Name	City	State
Italy	Istituto Auxologico Italiano IRCCS	Milan

Sponsors (1)

Lead Sponsor	Collaborator
Istituto Auxologico Italiano

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of subjects with neovascularization at follow-up visit	Evaluation of choroidal neovascularization	at 5 years of follow up